TAPENTADOL HYDROCHLORIDE

TAPENTADOL HYDROCHLORIDE was reported 33575 times

TAPENTADOL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PAROXYSMAL EXTREME PAIN DISORDER 18 0.7200
1 OPIATES NEGATIVE 7 0.3500
2 CORROSIVE OROPHARYNGEAL INJURY 8 0.2581
3 POLYNEUROPATHY IN MALIGNANT DISEASE 18 0.2195
4 CONFUSIONAL AROUSAL 19 0.1180
5 POST CHOLECYSTECTOMY SYNDROME 28 0.0989
6 PHARYNGEAL ENANTHEMA 6 0.0984
7 POST PROCEDURAL HYPOTHYROIDISM 20 0.0943
8 TENDER JOINT COUNT 7 0.0833
9 OCULAR PEMPHIGOID 10 0.0800
10 ASPARTATE AMINOTRANSFERASE 19 0.0779
11 GRANULOCYTE COUNT INCREASED 27 0.0667
12 DRUG WITHDRAWAL SYNDROME NEONATAL 944 0.0637
13 TOXICITY TO VARIOUS AGENTS 9959 0.0590
14 CHRONIC RESPIRATORY DISEASE 20 0.0567
15 BLOOD IMMUNOGLOBULIN A INCREASED 27 0.0501
16 DEGENERATIVE BONE DISEASE 19 0.0429
17 DRUG DOSE TITRATION NOT PERFORMED 78 0.0426
18 VITAMIN B12 INCREASED 29 0.0364
19 GLOMERULAR FILTRATION RATE INCREASED 28 0.0339
20 ELECTRIC SHOCK 29 0.0338
21 CONVULSIVE THRESHOLD LOWERED 13 0.0331
22 APPLICATION SITE INJURY 6 0.0316
23 DACTYLITIS 29 0.0295
24 OVERDOSE 5890 0.0273
25 DRUG DIVERSION 163 0.0264
26 RHEUMATOID FACTOR INCREASED 28 0.0251
27 ALLODYNIA 29 0.0248
28 BREAKTHROUGH PAIN 53 0.0229
29 ACCIDENTAL OVERDOSE 721 0.0197
30 CLUBBING 8 0.0196
31 DRUG ABUSE 1553 0.0186
32 REFLEXES ABNORMAL 12 0.0185
33 SHORT-BOWEL SYNDROME 12 0.0184
34 PARASOMNIA 13 0.0181
35 DRUG SCREEN NEGATIVE 29 0.0165
36 AMNESTIC DISORDER 8 0.0164
37 SEPSIS NEONATAL 13 0.0160
38 INTERVERTEBRAL DISCITIS 30 0.0159
39 JOINT NOISE 28 0.0142
40 POST HERPETIC NEURALGIA 20 0.0139
41 DEATH 11645 0.0135
42 SEROTONIN SYNDROME 249 0.0129
43 COMPLEX REGIONAL PAIN SYNDROME 19 0.0129
44 DROWNING 13 0.0128
45 WHITE BLOOD CELLS URINE POSITIVE 24 0.0127
46 MYOFASCIAL PAIN SYNDROME 9 0.0127
47 OPIATES POSITIVE 6 0.0125
48 ASPARTATE AMINOTRANSFERASE ABNORMAL 19 0.0125
49 BACTERIURIA 7 0.0124
50 MOUTH INJURY 18 0.0119
51 THERAPEUTIC RESPONSE INCREASED 11 0.0117
52 HEPATITIS C 128 0.0106
53 HYPERTHERMIA MALIGNANT 15 0.0101
54 APPLICATION SITE ULCER 7 0.0099
55 POLYMYALGIA RHEUMATICA 31 0.0097
56 ALCOHOL INTERACTION 18 0.0093
57 DRUG SCREEN POSITIVE 71 0.0090
58 FALSE POSITIVE INVESTIGATION RESULT 9 0.0089
59 HAEMOPERITONEUM 7 0.0087
60 MONOCYTE COUNT INCREASED 30 0.0083
61 MIOSIS 65 0.0081
62 SMALL INTESTINAL RESECTION 9 0.0077
63 APPLICATION SITE HYPERSENSITIVITY 9 0.0074
64 VITAMIN B12 DEFICIENCY 30 0.0074
65 SOMATIC SYMPTOM DISORDER 8 0.0074
66 HYPERAESTHESIA 59 0.0072
67 DEMYELINATION 29 0.0071
68 THROAT CLEARING 26 0.0069
69 BLOOD ALKALINE PHOSPHATASE ABNORMAL 6 0.0067
70 DRUG DEPENDENCE 1073 0.0067
71 SLEEP DEFICIT 14 0.0066
72 MYOCLONIC EPILEPSY 10 0.0066
73 ACCIDENT 78 0.0065
74 DRUG TOLERANCE 33 0.0065
75 ORAL MUCOSA EROSION 8 0.0065
76 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 8 0.0064
77 RESPIRATORY DEPRESSION 78 0.0064
78 PRODUCT SHAPE ISSUE 6 0.0063
79 HIV INFECTION 19 0.0063
80 POST-TRAUMATIC STRESS DISORDER 42 0.0063
81 PRODUCT MONITORING ERROR 9 0.0062
82 BLOOD PRESSURE SYSTOLIC DECREASED 27 0.0059
83 CLONUS 16 0.0058
84 IMMUNOGLOBULINS DECREASED 8 0.0058
85 PEPTIC ULCER 19 0.0057
86 ASTERIXIS 6 0.0056
87 PRODUCT DISTRIBUTION ISSUE 52 0.0056
88 ALCOHOL POISONING 15 0.0056
89 SPINAL DISORDER 53 0.0056
90 DELIRIUM 193 0.0056
91 DISTURBANCE IN SOCIAL BEHAVIOUR 13 0.0055
92 DRUG SCREEN FALSE POSITIVE 15 0.0054
93 CHOLECYSTITIS ACUTE 30 0.0053
94 TONGUE DISCOMFORT 22 0.0052
95 RESPIRATORY RATE DECREASED 16 0.0051
96 SUDDEN ONSET OF SLEEP 7 0.0050
97 VITAMIN D DEFICIENCY 49 0.0050
98 BLOOD URIC ACID INCREASED 29 0.0050
99 SECONDARY IMMUNODEFICIENCY 6 0.0049
100 MEDICAL PROCEDURE 8 0.0048
101 MEDICATION ERROR 267 0.0048
102 QUALITY OF LIFE DECREASED 64 0.0048
103 KNEE DEFORMITY 7 0.0047
104 GAZE PALSY 8 0.0047
105 ATROPHY 9 0.0046
106 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 12 0.0046
107 INTENTIONAL PRODUCT MISUSE 400 0.0046
108 DYSAESTHESIA 14 0.0046
109 DYSLIPIDAEMIA 23 0.0045
110 ORAL MUCOSAL ERYTHEMA 7 0.0045
111 RHINITIS ALLERGIC 20 0.0045
112 BUNDLE BRANCH BLOCK LEFT 19 0.0045
113 BLOOD LOSS ANAEMIA 10 0.0044
114 HYPERPARATHYROIDISM SECONDARY 11 0.0044
115 INADEQUATE ANALGESIA 37 0.0044
116 PRE-EXISTING CONDITION IMPROVED 27 0.0043
117 LOSS OF EMPLOYMENT 13 0.0043
118 WITHDRAWAL SYNDROME 180 0.0043
119 DRUG TITRATION ERROR 11 0.0043
120 STENOSIS 8 0.0043
121 SYSTEMIC INFECTION 7 0.0042
122 PULMONARY SEPSIS 6 0.0041
123 NASAL POLYPS 20 0.0041
124 SUBSTANCE ABUSE 33 0.0041
125 EUPHORIC MOOD 41 0.0040
126 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 27 0.0040
127 DRUG PRESCRIBING ERROR 76 0.0040
128 GINGIVITIS 21 0.0039
129 ADJUSTMENT DISORDER 5 0.0038
130 BLOOD PRESSURE DIASTOLIC DECREASED 28 0.0038
131 PUPILLARY REFLEX IMPAIRED 7 0.0038
132 BODY MASS INDEX INCREASED 5 0.0037
133 NEPHROGENIC ANAEMIA 17 0.0037
134 SOPOR 47 0.0035
135 SEDATION COMPLICATION 9 0.0035
136 HYPOPHYSITIS 7 0.0035
137 REACTION TO EXCIPIENT 8 0.0035
138 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 28 0.0034
139 DRUG WITHDRAWAL SYNDROME 293 0.0033
140 BENIGN PROSTATIC HYPERPLASIA 17 0.0033
141 BREAST CANCER METASTATIC 35 0.0033
142 RED BLOOD CELL SEDIMENTATION RATE INCREASED 36 0.0033
143 ABNORMAL LOSS OF WEIGHT 22 0.0032
144 FUNCTIONAL GASTROINTESTINAL DISORDER 11 0.0032
145 HYPOPNOEA 11 0.0032
146 SEDATION 82 0.0031
147 CANCER PAIN 8 0.0031
148 CACHEXIA 16 0.0031
149 HAEMOTHORAX 9 0.0031
150 CHRONIC GASTRITIS 7 0.0031
151 PSYCHOMOTOR SKILLS IMPAIRED 8 0.0031
152 INABILITY TO AFFORD MEDICATION 30 0.0030
153 POTENTIATING DRUG INTERACTION 10 0.0030
154 DRUG USE DISORDER 25 0.0030
155 SPINAL FUSION SURGERY 12 0.0030
156 ULCER 47 0.0030
157 INCOHERENT 19 0.0029
158 BRAIN DEATH 9 0.0029
159 AMYLOIDOSIS 5 0.0029
160 SLOW SPEECH 7 0.0029
161 LIVEDO RETICULARIS 6 0.0029
162 COMPLETED SUICIDE 237 0.0028
163 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 25 0.0028
164 INFLAMMATORY MARKER INCREASED 14 0.0028
165 TEMPERATURE INTOLERANCE 29 0.0028
166 HALLUCINATION 210 0.0028
167 CEREBRAL ATROPHY 11 0.0028
168 TRIGEMINAL NEURALGIA 11 0.0027
169 NEUTROPHIL COUNT INCREASED 28 0.0027
170 PNEUMONIA ASPIRATION 68 0.0027
171 ADRENAL INSUFFICIENCY 33 0.0027
172 HALLUCINATION, VISUAL 57 0.0027
173 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 6 0.0027
174 RADICULOPATHY 7 0.0027
175 ADRENAL DISORDER 5 0.0026
176 INTERVERTEBRAL DISC DEGENERATION 24 0.0026
177 SOCIAL AVOIDANT BEHAVIOUR 15 0.0026
178 DISABILITY 51 0.0026
179 IMPAIRED DRIVING ABILITY 29 0.0025
180 DRUG INTERACTION 404 0.0025
181 DRUG EFFECT INCREASED 8 0.0025
182 COORDINATION ABNORMAL 35 0.0025
183 OSTEOPENIA 38 0.0025
184 ALTERED STATE OF CONSCIOUSNESS 54 0.0025
185 INTERVERTEBRAL DISC PROTRUSION 54 0.0025
186 THROMBOCYTOSIS 9 0.0025
187 DISORIENTATION 97 0.0024
188 UNRESPONSIVE TO STIMULI 63 0.0024
189 SPEECH DISORDER DEVELOPMENTAL 7 0.0024
190 SELF-MEDICATION 10 0.0024
191 MYOCLONUS 29 0.0024
192 HYPERTENSIVE CRISIS 27 0.0024
193 NEURALGIA 59 0.0024
194 DEPENDENCE 133 0.0024
195 NECK INJURY 7 0.0024
196 EXPOSURE VIA INGESTION 6 0.0024
197 HALLUCINATIONS, MIXED 10 0.0024
198 URINE ANALYSIS ABNORMAL 7 0.0023
199 PRODUCT PHYSICAL ISSUE 47 0.0023
200 REBOUND ACID HYPERSECRETION 7 0.0023
201 BRADYPHRENIA 15 0.0023
202 THROMBOPHLEBITIS 8 0.0023
203 SPINAL OSTEOARTHRITIS 20 0.0023
204 URINARY RETENTION 75 0.0022
205 ILEUS PARALYTIC 10 0.0022
206 POISONING DELIBERATE 21 0.0022
207 FAECALOMA 12 0.0022
208 APNOEA 17 0.0022
209 PERFORMANCE STATUS DECREASED 10 0.0021
210 ATTENTION DEFICIT HYPERACTIVITY DISORDER 9 0.0021
211 AUTOIMMUNE THYROIDITIS 8 0.0021
212 PANIC REACTION 15 0.0021
213 NYSTAGMUS 11 0.0021
214 BLOOD TEST ABNORMAL 29 0.0021
215 HELICOBACTER INFECTION 21 0.0020
216 COGNITIVE DISORDER 95 0.0020
217 SOMNOLENCE 409 0.0020
218 END STAGE RENAL DISEASE 37 0.0020
219 ADVERSE EVENT 186 0.0020
220 FIBROMYALGIA 49 0.0020
221 MULTIPLE DRUG OVERDOSE 10 0.0020
222 ILEUS 25 0.0020
223 AGITATION 147 0.0020
224 IRON DEFICIENCY 9 0.0020
225 DELUSION 31 0.0020
226 EXPOSURE DURING PREGNANCY 124 0.0020
227 METASTASES TO LUNG 23 0.0020
228 INTENTIONAL OVERDOSE 127 0.0020
229 SUICIDE ATTEMPT 120 0.0020
230 HYPOGAMMAGLOBULINAEMIA 13 0.0020
231 RESTLESSNESS 72 0.0020
232 DRUG EFFECT DECREASED 105 0.0019
233 MYDRIASIS 25 0.0019
234 MENTAL IMPAIRMENT 47 0.0019
235 FEELING OF DESPAIR 9 0.0019
236 ACTINIC KERATOSIS 5 0.0019
237 DEPRESSED LEVEL OF CONSCIOUSNESS 76 0.0019
238 BLOOD UREA INCREASED 32 0.0019
239 DERMATITIS ALLERGIC 24 0.0019
240 POLYARTHRITIS 10 0.0019
241 SLEEP APNOEA SYNDROME 36 0.0019
242 SCREAMING 12 0.0019
243 HYPERHIDROSIS 240 0.0019
244 LOOSE TOOTH 6 0.0019
245 CONFUSIONAL STATE 297 0.0018
246 ASPHYXIA 15 0.0018
247 SOMNAMBULISM 12 0.0018
248 DYSPHEMIA 8 0.0018
249 ROTATOR CUFF SYNDROME 23 0.0018
250 MUSCLE TWITCHING 40 0.0017
251 FORMICATION 12 0.0017
252 BLOOD PRESSURE FLUCTUATION 41 0.0017
253 HANGOVER 6 0.0017
254 LOGORRHOEA 6 0.0017
255 SKIN ABRASION 8 0.0017
256 MENTAL STATUS CHANGES 47 0.0017
257 DRUG SPECIFIC ANTIBODY PRESENT 11 0.0017
258 POLYNEUROPATHY 20 0.0017
259 SELF-INJURIOUS IDEATION 7 0.0017
260 PRODUCT ADMINISTRATION INTERRUPTED 13 0.0017
261 RESTLESS LEGS SYNDROME 30 0.0016
262 ABNORMAL DREAMS 45 0.0016
263 MIDDLE INSOMNIA 30 0.0016
264 JOINT EFFUSION 11 0.0016
265 BODY HEIGHT DECREASED 17 0.0016
266 METASTASES TO BONE 26 0.0016
267 BLADDER PAIN 5 0.0016
268 HALLUCINATION, AUDITORY 25 0.0016
269 DRY MOUTH 127 0.0016
270 APPLICATION SITE REACTION 11 0.0016
271 THYROID MASS 6 0.0016
272 THINKING ABNORMAL 29 0.0016
273 DEVELOPMENTAL DELAY 14 0.0016
274 SKIN WARM 9 0.0015
275 CHRONIC KIDNEY DISEASE 117 0.0015
276 PERIPHERAL SENSORY NEUROPATHY 9 0.0015
277 DISTURBANCE IN ATTENTION 83 0.0015
278 HYPOVOLAEMIA 9 0.0015
279 CONSTIPATION 335 0.0015
280 BACTERIAL SEPSIS 5 0.0015
281 BLOOD ALKALINE PHOSPHATASE INCREASED 38 0.0015
282 ENERGY INCREASED 9 0.0015
283 ANKYLOSING SPONDYLITIS 20 0.0015
284 WRONG TECHNIQUE IN DRUG USAGE PROCESS 55 0.0015
285 OBSTRUCTION 6 0.0015
286 ANXIETY DISORDER 5 0.0015
287 INTRACRANIAL ANEURYSM 6 0.0015
288 SUSPECTED SUICIDE 7 0.0015
289 BLINDNESS TRANSIENT 11 0.0015
290 AMNESIA 97 0.0015
291 SPINAL COLUMN STENOSIS 7 0.0015
292 APPLICATION SITE DISCOLOURATION 6 0.0015
293 MOTOR DYSFUNCTION 15 0.0015
294 BIPOLAR DISORDER 16 0.0015
295 BACK INJURY 16 0.0015
296 MENISCUS INJURY 9 0.0015
297 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 9 0.0015
298 GASTROINTESTINAL TOXICITY 7 0.0015
299 CHOLANGITIS 9 0.0015
300 BEDRIDDEN 19 0.0014
301 ANAL INCONTINENCE 13 0.0014
302 DRUG DOSE OMISSION 238 0.0014
303 DRUG DISPENSING ERROR 22 0.0014
304 BLEPHAROSPASM 9 0.0014
305 SLEEP TERROR 6 0.0014
306 PHOTOPSIA 9 0.0014
307 OSTEOPOROSIS 57 0.0014
308 THERAPEUTIC RESPONSE DECREASED 84 0.0014
309 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
310 HYPERVENTILATION 8 0.0014
311 PETIT MAL EPILEPSY 7 0.0014
312 ASPIRATION 15 0.0014
313 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 14 0.0014
314 TREMOR 226 0.0014
315 PERIPHERAL VASCULAR DISORDER 7 0.0014
316 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
317 POISONING 17 0.0014
318 C-REACTIVE PROTEIN INCREASED 49 0.0013
319 FEELING DRUNK 10 0.0013
320 PRODUCT PRESCRIBING ERROR 32 0.0013
321 SINUS TACHYCARDIA 19 0.0013
322 IMPAIRED GASTRIC EMPTYING 18 0.0013
323 RIB FRACTURE 27 0.0013
324 HYPERTHERMIA 10 0.0013
325 LYMPHOEDEMA 9 0.0013
326 DEPRESSION 295 0.0013
327 BEHAVIOUR DISORDER 7 0.0013
328 CONCUSSION 10 0.0013
329 SEIZURE 149 0.0013
330 DYSKINESIA 52 0.0013
331 DYSARTHRIA 48 0.0013
332 TACHYCARDIA 113 0.0013
333 HAND FRACTURE 9 0.0013
334 TOOTH FRACTURE 14 0.0013
335 HEAD INJURY 40 0.0013
336 ENDOMETRIOSIS 6 0.0013
337 HYPERSOMNIA 36 0.0013
338 DYSPHAGIA 119 0.0013
339 PSYCHOTIC DISORDER 37 0.0013
340 PAIN 767 0.0012
341 COLD SWEAT 22 0.0012
342 SUICIDAL IDEATION 114 0.0012
343 HUMERUS FRACTURE 6 0.0012
344 ROAD TRAFFIC ACCIDENT 52 0.0012
345 ABNORMAL BEHAVIOUR 49 0.0012
346 MAJOR DEPRESSION 9 0.0012
347 NEUROPATHY PERIPHERAL 117 0.0012
348 SUDDEN DEATH 13 0.0012
349 CARDIAC VALVE DISEASE 7 0.0012
350 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 87 0.0012
351 SPINAL OPERATION 15 0.0012
352 IMPAIRED WORK ABILITY 26 0.0012
353 HERPES VIRUS INFECTION 7 0.0012
354 LIMB INJURY 33 0.0012
355 MULTIPLE SCLEROSIS 58 0.0012
356 DEPRESSED MOOD 64 0.0012
357 PSYCHOMOTOR HYPERACTIVITY 20 0.0012
358 HYPOGLYCAEMIA 58 0.0012
359 LOSS OF CONSCIOUSNESS 153 0.0012
360 PEMPHIGOID 9 0.0012
361 APHASIA 36 0.0012
362 RED BLOOD CELL COUNT DECREASED 34 0.0012
363 JOINT STIFFNESS 31 0.0012
364 ENCEPHALOPATHY 29 0.0012
365 RESPIRATORY DISORDER 35 0.0012
366 SYMPTOM RECURRENCE 7 0.0012
367 ACTIVITIES OF DAILY LIVING IMPAIRED 23 0.0012
368 FOOT FRACTURE 22 0.0012
369 FEELING JITTERY 22 0.0012
370 PRESYNCOPE 28 0.0012
371 GLYCOSYLATED HAEMOGLOBIN INCREASED 29 0.0011
372 PRESCRIBED OVERDOSE 22 0.0011
373 PRODUCT QUALITY ISSUE 154 0.0011
374 BALANCE DISORDER 98 0.0011
375 FEELING ABNORMAL 271 0.0011
376 MIGRAINE 107 0.0011
377 HIP ARTHROPLASTY 17 0.0011
378 MUCOSAL INFLAMMATION 29 0.0011
379 BACK DISORDER 18 0.0011
380 HAEMATEMESIS 28 0.0011
381 GASTRITIS 29 0.0011
382 POLYURIA 9 0.0011
383 ANKLE FRACTURE 17 0.0011
384 EMPHYSEMA 11 0.0011
385 NEUROTOXICITY 19 0.0011
386 NERVE COMPRESSION 10 0.0011
387 CYANOSIS 17 0.0011
388 EATING DISORDER 23 0.0011
389 AGGRESSION 54 0.0011
390 DRUG EFFECT INCOMPLETE 39 0.0011
391 BURSITIS 13 0.0011
392 TYPE 2 DIABETES MELLITUS 36 0.0011
393 ARTERIOSCLEROSIS 10 0.0011
394 BLOOD PRESSURE ABNORMAL 21 0.0011
395 MALIGNANT NEOPLASM PROGRESSION 108 0.0011
396 NERVOUSNESS 55 0.0011
397 RESPIRATORY ARREST 29 0.0011
398 TROPONIN INCREASED 8 0.0011
399 HYPOXIA 37 0.0010
400 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 18 0.0010
401 OXYGEN SATURATION DECREASED 59 0.0010
402 APPLICATION SITE PAIN 23 0.0010
403 PARANOIA 18 0.0010
404 GLAUCOMA 20 0.0010
405 MENTAL DISORDER 45 0.0010
406 DYSURIA 38 0.0010
407 ANAPHYLACTIC REACTION 57 0.0010
408 PRODUCT DOSE OMISSION 67 0.0010
409 THERAPEUTIC RESPONSE UNEXPECTED 46 0.0010
410 AFFECTIVE DISORDER 8 0.0010
411 PANIC ATTACK 37 0.0010
412 APPLICATION SITE BURN 5 0.0010
413 EPILEPSY 31 0.0010
414 ANXIETY 288 0.0010
415 ENCEPHALITIS 7 0.0010
416 LIGAMENT SPRAIN 10 0.0010
417 UNEVALUABLE EVENT 76 0.0010
418 ARTHRITIS 79 0.0010
419 TINNITUS 46 0.0010
420 INSOMNIA 266 0.0010
421 FALL 332 0.0010
422 APPLICATION SITE ERYTHEMA 26 0.0010
423 WHITE BLOOD CELL COUNT INCREASED 38 0.0010
424 INTENTIONAL SELF-INJURY 20 0.0010
425 MUSCLE TIGHTNESS 16 0.0010
426 RETCHING 21 0.0010
427 NECK PAIN 55 0.0010
428 DECUBITUS ULCER 8 0.0010
429 BACK PAIN 227 0.0010
430 CARDIOMEGALY 12 0.0010
431 STATUS EPILEPTICUS 11 0.0010
432 HYPERCALCAEMIA 12 0.0010
433 OLIGURIA 6 0.0010
434 NEPHROPATHY 9 0.0010
435 CRYING 35 0.0010
436 DRUG ERUPTION 17 0.0010
437 BRONCHITIS 71 0.0010
438 MUSCULAR WEAKNESS 109 0.0010
439 THROAT IRRITATION 43 0.0010
440 BURNING SENSATION 67 0.0010
441 SURGERY 56 0.0010
442 INTESTINAL OBSTRUCTION 36 0.0010
443 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 52 0.0009
444 PERIPHERAL COLDNESS 13 0.0009
445 RENAL PAIN 10 0.0009
446 JOINT INJURY 20 0.0009
447 BLOOD CREATININE INCREASED 61 0.0009
448 ABASIA 23 0.0009
449 BREAST TENDERNESS 7 0.0009
450 SYNCOPE 93 0.0009
451 NAUSEA 735 0.0009
452 CARPAL TUNNEL SYNDROME 13 0.0009
453 DYSTONIA 18 0.0009
454 HIATUS HERNIA 12 0.0009
455 PRURITUS GENERALISED 20 0.0009
456 ECONOMIC PROBLEM 14 0.0009
457 HYSTERECTOMY 8 0.0009
458 AUTOIMMUNE DISORDER 9 0.0009
459 SEASONAL ALLERGY 13 0.0009
460 SPEECH DISORDER 48 0.0009
461 PULMONARY OEDEMA 41 0.0009
462 KNEE OPERATION 9 0.0009
463 DYSGRAPHIA 6 0.0009
464 PHARYNGEAL OEDEMA 14 0.0009
465 ASTHENOPIA 5 0.0009
466 CARDIO-RESPIRATORY ARREST 38 0.0009
467 INTENTIONAL DRUG MISUSE 19 0.0009
468 ACUTE KIDNEY INJURY 139 0.0009
469 PARALYSIS 13 0.0009
470 RENAL FAILURE 120 0.0009
471 HYPOPHAGIA 23 0.0009
472 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 64 0.0009
473 NERVE INJURY 10 0.0009
474 FEELING COLD 25 0.0009
475 THERAPY PARTIAL RESPONDER 14 0.0009
476 PALPITATIONS 105 0.0009
477 NIGHTMARE 31 0.0009
478 BREAST MASS 6 0.0009
479 ANGIOPATHY 5 0.0009
480 SKIN INFECTION 10 0.0009
481 DRUG INTOLERANCE 86 0.0009
482 RHEUMATOID ARTHRITIS 101 0.0009
483 ILL-DEFINED DISORDER 54 0.0009
484 POSTOPERATIVE WOUND INFECTION 6 0.0009
485 HYPONATRAEMIA 50 0.0009
486 LETHARGY 51 0.0009
487 LIVER FUNCTION TEST INCREASED 19 0.0009
488 NASAL CONGESTION 52 0.0009
489 RESPIRATORY TRACT INFECTION 23 0.0009
490 SLEEP DISORDER 62 0.0009
491 HEART RATE INCREASED 87 0.0009
492 TREATMENT NONCOMPLIANCE 48 0.0009
493 SCAB 10 0.0009
494 EYE MOVEMENT DISORDER 6 0.0009
495 EXOSTOSIS 8 0.0009
496 OSTEOARTHRITIS 37 0.0009
497 VERTIGO 53 0.0009
498 AUTOIMMUNE HEPATITIS 6 0.0009
499 ORTHOSTATIC HYPOTENSION 15 0.0009
500 ELECTROLYTE IMBALANCE 10 0.0009
501 HEPATIC ENCEPHALOPATHY 8 0.0009
502 INTENTIONAL PRODUCT USE ISSUE 75 0.0009
503 STEVENS-JOHNSON SYNDROME 19 0.0009
504 BLOOD GLUCOSE DECREASED 41 0.0009
505 TUBULOINTERSTITIAL NEPHRITIS 16 0.0009
506 SPINAL PAIN 10 0.0009
507 CHILLS 100 0.0009
508 SPINAL FRACTURE 17 0.0008
509 DRUG ADMINISTRATION ERROR 26 0.0008
510 BRADYKINESIA 5 0.0008
511 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
512 GASTRIC DISORDER 29 0.0008
513 PRODUCT SUPPLY ISSUE 6 0.0008
514 VOMITING 392 0.0008
515 DIZZINESS 414 0.0008
516 ADVERSE REACTION 11 0.0008
517 NEPHROLITHIASIS 38 0.0008
518 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 43 0.0008
519 NOCTURIA 10 0.0008
520 DYSSTASIA 24 0.0008
521 INTENTIONAL UNDERDOSE 6 0.0008
522 HYPERTENSION 173 0.0008
523 IRRITABILITY 49 0.0008
524 MUSCULOSKELETAL DISCOMFORT 14 0.0008
525 URINARY INCONTINENCE 24 0.0008
526 TOOTH DISORDER 18 0.0008
527 KNEE ARTHROPLASTY 17 0.0008
528 PRODUCT USE IN UNAPPROVED INDICATION 200 0.0008
529 MUSCLE SPASMS 148 0.0008
530 PHARYNGITIS 10 0.0008
531 HYPOTENSION 161 0.0008
532 DRY EYE 40 0.0008
533 SWOLLEN TONGUE 25 0.0008
534 ALANINE AMINOTRANSFERASE INCREASED 49 0.0008
535 BRAIN INJURY 8 0.0008
536 METASTASES TO LIVER 14 0.0008
537 PAROSMIA 6 0.0008
538 APPLICATION SITE PRURITUS 18 0.0008
539 CONTRAINDICATED PRODUCT ADMINISTERED 24 0.0008
540 BLOOD PRESSURE INCREASED 121 0.0008
541 HYPOTHERMIA 8 0.0008
542 DERMATITIS CONTACT 9 0.0008
543 DRUG INEFFECTIVE 1039 0.0008
544 MICTURITION URGENCY 9 0.0008
545 WRONG DRUG ADMINISTERED 7 0.0008
546 SUBARACHNOID HAEMORRHAGE 8 0.0008
547 ACIDOSIS 6 0.0008
548 THIRST 14 0.0008
549 GASTROOESOPHAGEAL REFLUX DISEASE 63 0.0008
550 METABOLIC ACIDOSIS 25 0.0008
551 ACUTE RESPIRATORY FAILURE 15 0.0008
552 INITIAL INSOMNIA 8 0.0008
553 DECREASED APPETITE 181 0.0008
554 HYPOAESTHESIA 116 0.0008
555 WEIGHT DECREASED 216 0.0008
556 PNEUMONIA 250 0.0008
557 PALLOR 21 0.0008
558 MOOD ALTERED 21 0.0008
559 BRAIN NEOPLASM 7 0.0008
560 HYPOKINESIA 11 0.0008
561 CHEST PAIN 140 0.0008
562 CHOLECYSTITIS 9 0.0008
563 GINGIVAL PAIN 6 0.0008
564 GASTROENTERITIS 11 0.0008
565 ASTHMA 85 0.0008
566 CARDIAC ARREST 62 0.0008
567 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 36 0.0007
568 SENSORY DISTURBANCE 12 0.0007
569 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
570 INFECTION 108 0.0007
571 JOINT RANGE OF MOTION DECREASED 10 0.0007
572 SENSORY LOSS 6 0.0007
573 FEAR 20 0.0007
574 POOR QUALITY SLEEP 16 0.0007
575 MEMORY IMPAIRMENT 102 0.0007
576 MUSCULOSKELETAL STIFFNESS 65 0.0007
577 DECREASED ACTIVITY 8 0.0007
578 FEEDING DISORDER 15 0.0007
579 THROAT TIGHTNESS 20 0.0007
580 PRODUCT TASTE ABNORMAL 10 0.0007
581 POST PROCEDURAL INFECTION 6 0.0007
582 HAEMORRHAGE INTRACRANIAL 11 0.0007
583 COMA 35 0.0007
584 HEAD DISCOMFORT 13 0.0007
585 ASTHENIA 276 0.0007
586 MUSCLE SPASTICITY 9 0.0007
587 SMALL INTESTINAL OBSTRUCTION 9 0.0007
588 BLOOD TESTOSTERONE DECREASED 5 0.0007
589 TENDON RUPTURE 9 0.0007
590 PRODUCT ADHESION ISSUE 26 0.0007
591 INJURY 51 0.0007
592 APPLICATION SITE IRRITATION 9 0.0007
593 DENTAL CARIES 8 0.0007
594 DISCOMFORT 44 0.0007
595 HYPOTHYROIDISM 23 0.0007
596 INSURANCE ISSUE 11 0.0007
597 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
598 EAR INFECTION 19 0.0007
599 SINUS DISORDER 14 0.0007
600 BLADDER DISORDER 7 0.0007
601 HYPOTONIA 7 0.0007
602 BRONCHOSPASM 10 0.0007
603 MYOCARDITIS 8 0.0007
604 ARRHYTHMIA 33 0.0007
605 SKIN ULCER 18 0.0007
606 GAIT DISTURBANCE 133 0.0007
607 CARDIAC MURMUR 6 0.0007
608 HEPATIC CIRRHOSIS 13 0.0007
609 GENERAL PHYSICAL HEALTH DETERIORATION 80 0.0007
610 OBESITY 11 0.0007
611 MALAISE 302 0.0007
612 BODY TEMPERATURE INCREASED 14 0.0007
613 APATHY 10 0.0007
614 GASTRIC ULCER 13 0.0007
615 SINUSITIS 70 0.0007
616 GRIP STRENGTH DECREASED 6 0.0007
617 SARS-COV-2 TEST POSITIVE 9 0.0007
618 BLOOD IRON DECREASED 8 0.0007
619 ATAXIA 8 0.0007
620 ABDOMINAL PAIN UPPER 138 0.0007
621 GASTROINTESTINAL INFECTION 6 0.0007
622 MUSCULOSKELETAL PAIN 35 0.0007
623 LOSS OF LIBIDO 6 0.0007
624 HEADACHE 418 0.0007
625 ARTHROPATHY 37 0.0007
626 BLOOD POTASSIUM DECREASED 20 0.0007
627 INFUSION RELATED REACTION 44 0.0007
628 DRUG ADMINISTERED AT INAPPROPRIATE SITE 7 0.0007
629 LEUKOCYTOSIS 12 0.0007
630 KIDNEY INFECTION 13 0.0007
631 JOINT DISLOCATION 7 0.0007
632 TACHYPNOEA 9 0.0007
633 LOCALISED INFECTION 16 0.0007
634 CYSTITIS 21 0.0007
635 CEREBRAL INFARCTION 16 0.0007
636 APPLICATION SITE RASH 9 0.0007
637 IRRITABLE BOWEL SYNDROME 14 0.0007
638 FACE OEDEMA 11 0.0007
639 PRESCRIBED UNDERDOSE 13 0.0007
640 ANGER 22 0.0006
641 UROSEPSIS 6 0.0006
642 THYROID DISORDER 10 0.0006
643 CYTOKINE RELEASE SYNDROME 13 0.0006
644 CONVULSION 37 0.0006
645 PHARYNGITIS STREPTOCOCCAL 7 0.0006
646 GENERALISED OEDEMA 8 0.0006
647 SKIN LACERATION 7 0.0006
648 ERYTHEMA MULTIFORME 6 0.0006
649 DYSPNOEA 364 0.0006
650 TOOTH EXTRACTION 8 0.0006
651 SCAR 11 0.0006
652 NERVOUS SYSTEM DISORDER 20 0.0006
653 LEUKOPENIA 32 0.0006
654 SQUAMOUS CELL CARCINOMA 6 0.0006
655 HOT FLUSH 48 0.0006
656 STAPHYLOCOCCAL INFECTION 21 0.0006
657 GASTROINTESTINAL PAIN 7 0.0006
658 FEELING HOT 39 0.0006
659 WEIGHT INCREASED 142 0.0006
660 SUBDURAL HAEMATOMA 9 0.0006
661 MOOD SWINGS 20 0.0006
662 HYPERKALAEMIA 22 0.0006
663 URINARY TRACT INFECTION 107 0.0006
664 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
665 VISION BLURRED 86 0.0006
666 THERAPY NON-RESPONDER 28 0.0006
667 PANCREATITIS ACUTE 14 0.0006
668 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
669 HERNIA 12 0.0006
670 DIZZINESS POSTURAL 6 0.0006
671 PAIN IN EXTREMITY 182 0.0006
672 EMOTIONAL DISORDER 19 0.0006
673 GALLBLADDER DISORDER 11 0.0006
674 PRODUCT AVAILABILITY ISSUE 14 0.0006
675 ORAL HERPES 12 0.0006
676 LIMB DISCOMFORT 19 0.0006
677 CHOLECYSTECTOMY 7 0.0006
678 COELIAC DISEASE 6 0.0006
679 THERAPY CHANGE 6 0.0006
680 IMMUNE SYSTEM DISORDER 8 0.0006
681 PULMONARY MASS 9 0.0006
682 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
683 ANAEMIA 113 0.0006
684 SINUS CONGESTION 8 0.0006
685 NASOPHARYNGITIS 109 0.0006
686 FATIGUE 457 0.0006
687 PRODUCTIVE COUGH 28 0.0006
688 MUSCLE RIGIDITY 7 0.0006
689 EAR DISCOMFORT 6 0.0006
690 BLOOD SODIUM DECREASED 11 0.0006
691 DIABETIC KETOACIDOSIS 14 0.0006
692 CONDITION AGGRAVATED 177 0.0006
693 CONTUSION 56 0.0006
694 FRACTURE 11 0.0006
695 BLOOD MAGNESIUM DECREASED 5 0.0006
696 HUNGER 8 0.0006
697 WEIGHT FLUCTUATION 6 0.0006
698 LOCAL SWELLING 10 0.0006
699 DERMATITIS 12 0.0006
700 BLOOD PRESSURE DECREASED 38 0.0006
701 ARTHRALGIA 237 0.0006
702 SKIN REACTION 8 0.0006
703 THERAPY CESSATION 29 0.0006
704 PERIPHERAL SWELLING 87 0.0006
705 CYST 7 0.0006
706 HEPATIC FAILURE 17 0.0006
707 INFLAMMATION 29 0.0006
708 GOUT 10 0.0006
709 IMPAIRED QUALITY OF LIFE 8 0.0006
710 DEEP VEIN THROMBOSIS 36 0.0006
711 COLITIS 21 0.0006
712 ABDOMINAL PAIN LOWER 14 0.0006
713 TOOTHACHE 10 0.0006
714 UPPER LIMB FRACTURE 11 0.0006
715 POLLAKIURIA 23 0.0006
716 PELVIC PAIN 10 0.0005
717 ABDOMINAL PAIN 128 0.0005
718 RESPIRATORY FAILURE 40 0.0005
719 HEPATITIS 14 0.0005
720 GASTROINTESTINAL DISORDER 49 0.0005
721 STOMATITIS 33 0.0005
722 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
723 LIP SWELLING 18 0.0005
724 DYSPEPSIA 53 0.0005
725 RENAL INJURY 16 0.0005
726 GAIT INABILITY 18 0.0005
727 URTICARIA 90 0.0005
728 CHEST DISCOMFORT 55 0.0005
729 SNEEZING 12 0.0005
730 DEHYDRATION 71 0.0005
731 ORAL CANDIDIASIS 7 0.0005
732 HIP FRACTURE 17 0.0005
733 SEPTIC SHOCK 23 0.0005
734 CIRCULATORY COLLAPSE 9 0.0005
735 FEBRILE NEUTROPENIA 35 0.0005
736 MYOCARDIAL ISCHAEMIA 6 0.0005
737 DIABETES MELLITUS 40 0.0005
738 SWELLING 49 0.0005
739 ADVERSE DRUG REACTION 47 0.0005
740 SKIN DISCOLOURATION 24 0.0005
741 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
742 PRURITUS 200 0.0005
743 AFFECT LABILITY 5 0.0005
744 MUSCULOSKELETAL CHEST PAIN 8 0.0005
745 OEDEMA PERIPHERAL 63 0.0005
746 MOBILITY DECREASED 37 0.0005
747 THERAPEUTIC PRODUCT EFFECT DECREASED 23 0.0005
748 ATRIAL FIBRILLATION 50 0.0005
749 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 104 0.0005
750 DIARRHOEA 331 0.0005
751 EMOTIONAL DISTRESS 62 0.0005
752 SEXUAL DYSFUNCTION 6 0.0005
753 FLATULENCE 29 0.0005
754 INFLUENZA 57 0.0005
755 EYE SWELLING 19 0.0005
756 SKIN LESION 14 0.0005
757 ACUTE MYOCARDIAL INFARCTION 15 0.0005
758 RESPIRATORY DISTRESS 14 0.0005
759 PYREXIA 175 0.0005
760 FOETAL EXPOSURE DURING PREGNANCY 41 0.0005
761 CARDIAC DISORDER 47 0.0005
762 SCIATICA 8 0.0005
763 HYPERSENSITIVITY 93 0.0005
764 DIPLOPIA 13 0.0005
765 RENAL IMPAIRMENT 42 0.0005
766 MOVEMENT DISORDER 16 0.0005
767 HYPOKALAEMIA 23 0.0005
768 ABDOMINAL DISTENSION 52 0.0005
769 DEVICE OCCLUSION 7 0.0005
770 LYMPHOPENIA 7 0.0005
771 ANHEDONIA 13 0.0005
772 SCHIZOPHRENIA 6 0.0005
773 BLOOD POTASSIUM INCREASED 8 0.0005
774 NO THERAPEUTIC RESPONSE 6 0.0005
775 ASPARTATE AMINOTRANSFERASE INCREASED 26 0.0005
776 RECTAL HAEMORRHAGE 21 0.0005
777 HEART RATE DECREASED 17 0.0005
778 PULMONARY EMBOLISM 46 0.0005
779 HEPATIC STEATOSIS 9 0.0005
780 PARAESTHESIA 76 0.0005
781 BACTERIAL INFECTION 9 0.0005
782 HEPATIC FUNCTION ABNORMAL 18 0.0005
783 FUNGAL INFECTION 16 0.0005
784 SKIN DISORDER 16 0.0005
785 PRODUCT USE ISSUE 90 0.0005
786 VISUAL IMPAIRMENT 59 0.0005
787 INCORRECT ROUTE OF DRUG ADMINISTRATION 17 0.0005
788 BRAIN OEDEMA 6 0.0005
789 PANCREATITIS 25 0.0005
790 ELECTROCARDIOGRAM QT PROLONGED 17 0.0005
791 DYSGEUSIA 35 0.0005
792 MYALGIA 80 0.0005
793 CHOLESTASIS 9 0.0005
794 PROCEDURAL PAIN 13 0.0005
795 DRUG RESISTANCE 12 0.0005
796 HYPERGLYCAEMIA 17 0.0005
797 NEUTROPHIL COUNT DECREASED 19 0.0005
798 OROPHARYNGEAL PAIN 43 0.0005
799 NEOPLASM MALIGNANT 31 0.0005
800 HYPOAESTHESIA ORAL 7 0.0005
801 RHINORRHOEA 30 0.0005
802 BLISTER 26 0.0005
803 FLUSHING 47 0.0005
804 INFLUENZA LIKE ILLNESS 38 0.0005
805 RASH PRURITIC 25 0.0005
806 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
807 PULMONARY CONGESTION 6 0.0005
808 VIRAL INFECTION 15 0.0005
809 EYE HAEMORRHAGE 6 0.0004
810 RASH MACULO-PAPULAR 10 0.0004
811 BASAL CELL CARCINOMA 7 0.0004
812 ISCHAEMIC STROKE 8 0.0004
813 LIVER INJURY 11 0.0004
814 GLOSSODYNIA 10 0.0004
815 BLOOD CALCIUM DECREASED 5 0.0004
816 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
817 COUGH 124 0.0004
818 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
819 BLINDNESS 18 0.0004
820 MULTIPLE SCLEROSIS RELAPSE 30 0.0004
821 CORONARY ARTERY OCCLUSION 6 0.0004
822 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
823 HERPES ZOSTER 25 0.0004
824 NIGHT SWEATS 14 0.0004
825 TOOTH LOSS 9 0.0004
826 DIVERTICULITIS 12 0.0004
827 ORAL DISCOMFORT 6 0.0004
828 RHABDOMYOLYSIS 18 0.0004
829 HOSPITALISATION 66 0.0004
830 ANGIOEDEMA 19 0.0004
831 ERECTILE DYSFUNCTION 11 0.0004
832 DYSPHONIA 25 0.0004
833 MOUTH ULCERATION 9 0.0004
834 BONE PAIN 25 0.0004
835 PHOTOPHOBIA 8 0.0004
836 OEDEMA 23 0.0004
837 THERAPEUTIC RESPONSE SHORTENED 14 0.0004
838 SEPSIS 47 0.0004
839 PROTEINURIA 8 0.0004
840 ILLNESS 43 0.0004
841 PARAESTHESIA ORAL 6 0.0004
842 BONE DENSITY DECREASED 13 0.0004
843 SWELLING FACE 27 0.0004
844 JOINT SWELLING 50 0.0004
845 LIVER FUNCTION TEST ABNORMAL 12 0.0004
846 EAR PAIN 8 0.0004
847 CARDIAC FAILURE 33 0.0004
848 HEPATIC ENZYME INCREASED 28 0.0004
849 MELAENA 9 0.0004
850 CEREBROVASCULAR ACCIDENT 69 0.0004
851 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
852 TRANSAMINASES INCREASED 9 0.0004
853 ALOPECIA 79 0.0004
854 ORAL PAIN 9 0.0004
855 RASH PAPULAR 9 0.0004
856 AGEUSIA 10 0.0004
857 PREMATURE BABY 12 0.0004
858 CARDIAC FAILURE CONGESTIVE 32 0.0004
859 PRODUCT ADMINISTRATION ERROR 8 0.0004
860 DEMENTIA 11 0.0004
861 INTERSTITIAL LUNG DISEASE 19 0.0004
862 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
863 GASTROENTERITIS VIRAL 7 0.0004
864 OFF LABEL USE 339 0.0004
865 OSTEOMYELITIS 7 0.0004
866 BONE DISORDER 7 0.0004
867 LIVER DISORDER 17 0.0004
868 DRUG-INDUCED LIVER INJURY 12 0.0004
869 PRODUCT DOSE OMISSION ISSUE 112 0.0004
870 COLITIS ULCERATIVE 17 0.0004
871 BRADYCARDIA 20 0.0004
872 CELLULITIS 19 0.0004
873 ABSCESS 6 0.0004
874 ABDOMINAL DISCOMFORT 63 0.0004
875 ASCITES 11 0.0004
876 RASH MACULAR 13 0.0004
877 JAUNDICE 10 0.0004
878 GASTROINTESTINAL HAEMORRHAGE 31 0.0004
879 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
880 LYMPHADENOPATHY 13 0.0004
881 AKATHISIA 5 0.0004
882 ACUTE HEPATIC FAILURE 5 0.0004
883 LACRIMATION INCREASED 11 0.0004
884 RASH 158 0.0004
885 VISUAL ACUITY REDUCED 12 0.0004
886 COAGULOPATHY 6 0.0004
887 APHONIA 5 0.0004
888 WOUND 10 0.0004
889 INCORRECT DRUG ADMINISTRATION DURATION 10 0.0004
890 CARDIOVASCULAR DISORDER 9 0.0004
891 HEART RATE IRREGULAR 8 0.0004
892 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
893 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
894 HAEMATURIA 12 0.0004
895 TREATMENT FAILURE 29 0.0003
896 ANGINA PECTORIS 10 0.0003
897 PLATELET COUNT DECREASED 37 0.0003
898 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
899 PULMONARY HYPERTENSION 7 0.0003
900 BLOOD GLUCOSE ABNORMAL 6 0.0003
901 THROMBOSIS 26 0.0003
902 FEMUR FRACTURE 10 0.0003
903 AGRANULOCYTOSIS 6 0.0003
904 VAGINAL HAEMORRHAGE 14 0.0003
905 BLOOD CHOLESTEROL INCREASED 15 0.0003
906 PRODUCT PRESCRIBING ISSUE 7 0.0003
907 DISEASE PROGRESSION 38 0.0003
908 WHEEZING 19 0.0003
909 PSORIATIC ARTHROPATHY 13 0.0003
910 COVID-19 56 0.0003
911 FLUID RETENTION 16 0.0003
912 LOWER LIMB FRACTURE 6 0.0003
913 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 56 0.0003
914 CHROMATURIA 7 0.0003
915 RASH GENERALISED 8 0.0003
916 CHOKING 6 0.0003
917 LABORATORY TEST ABNORMAL 9 0.0003
918 HAEMATOCRIT DECREASED 6 0.0003
919 NEUTROPENIA 41 0.0003
920 PROSTATE CANCER 24 0.0003
921 FREQUENT BOWEL MOVEMENTS 8 0.0003
922 THERAPY INTERRUPTED 21 0.0003
923 PNEUMONITIS 8 0.0003
924 TARDIVE DYSKINESIA 8 0.0003
925 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
926 PLEURAL EFFUSION 17 0.0003
927 HYPOACUSIS 12 0.0003
928 PRODUCT SUBSTITUTION ISSUE 16 0.0003
929 FAECES DISCOLOURED 6 0.0003
930 EXTRA DOSE ADMINISTERED 11 0.0003
931 DEAFNESS 7 0.0003
932 LUNG NEOPLASM MALIGNANT 11 0.0003
933 MYOCARDIAL INFARCTION 46 0.0003
934 BLOOD URINE PRESENT 5 0.0003
935 ACCIDENTAL EXPOSURE TO PRODUCT 27 0.0003
936 SHOCK 6 0.0003
937 PAIN OF SKIN 7 0.0003
938 RENAL DISORDER 12 0.0003
939 HAEMATOCHEZIA 14 0.0003
940 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
941 ERYTHEMA 52 0.0003
942 RASH ERYTHEMATOUS 12 0.0003
943 PANCYTOPENIA 14 0.0003
944 THROMBOCYTOPENIA 28 0.0003
945 EYE PAIN 14 0.0002
946 UNDERDOSE 18 0.0002
947 INTENTIONAL DOSE OMISSION 7 0.0002
948 IMPAIRED HEALING 8 0.0002
949 EPISTAXIS 18 0.0002
950 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
951 CATARACT 14 0.0002
952 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
953 ANAPHYLACTIC SHOCK 6 0.0002
954 PLASMA CELL MYELOMA 9 0.0002
955 LUNG DISORDER 11 0.0002
956 HAEMOGLOBIN DECREASED 23 0.0002
957 HAEMORRHAGE 23 0.0002
958 OSTEONECROSIS 7 0.0002
959 PAIN IN JAW 6 0.0002
960 OCULAR HYPERAEMIA 10 0.0002
961 EXPIRED PRODUCT ADMINISTERED 7 0.0002
962 MATERNAL EXPOSURE DURING PREGNANCY 18 0.0002
963 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
964 MYELOSUPPRESSION 7 0.0002
965 INCORRECT DOSE ADMINISTERED 44 0.0002
966 BLOOD GLUCOSE INCREASED 36 0.0002
967 RENAL FAILURE ACUTE 8 0.0002
968 DEVICE DISLOCATION 8 0.0002
969 EYE DISORDER 6 0.0002
970 NO ADVERSE EVENT 33 0.0002
971 ABORTION SPONTANEOUS 7 0.0002
972 CEREBRAL HAEMORRHAGE 6 0.0002
973 BREAST CANCER 15 0.0002
974 PSORIASIS 21 0.0002
975 DYSPNOEA EXERTIONAL 6 0.0002
976 ACNE 12 0.0002
977 SKIN IRRITATION 7 0.0002
978 INJECTION SITE BRUISING 12 0.0002
979 SKIN EXFOLIATION 12 0.0001
980 DEVICE ISSUE 12 0.0001
981 ECZEMA 7 0.0001
982 INJECTION SITE PAIN 40 0.0001
983 DEVICE MALFUNCTION 9 0.0001
984 PRODUCT STORAGE ERROR 11 0.0001
985 EYE IRRITATION 7 0.0001
986 DRY SKIN 16 0.0001
987 INJECTION SITE REACTION 8 0.0001
988 DERMATITIS ATOPIC 6 0.0001
989 INJECTION SITE HAEMORRHAGE 8 0.0001
990 SKIN BURNING SENSATION 6 0.0001
991 INJECTION SITE SWELLING 6 0.0001
992 INJECTION SITE ERYTHEMA 9 0.0001